Novel strategies for the buccal delivery of macromolecules
Author
dc.contributor.author
Morales, Javier O.
Author
dc.contributor.author
McConville, Jason T.
Admission date
dc.date.accessioned
2019-03-15T16:06:37Z
Available date
dc.date.available
2019-03-15T16:06:37Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Drug Development and Industrial Pharmacy, Volumen 40, Issue 5, 2018, Pages 579-590
Identifier
dc.identifier.issn
15205762
Identifier
dc.identifier.issn
03639045
Identifier
dc.identifier.other
10.3109/03639045.2014.892960
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/166166
Abstract
dc.description.abstract
For years now, the delivery of small molecules through the buccal mucosal route has been described in the literature, but it has only been over the past decade that investigations into macromolecule delivery via the buccal route have sharply increased. The administration of macromolecules such as proteins and peptides, antibodies, or nucleic acids by buccal administration would be greatly enhanced due to the avoidance of the gastrointestinal conditions, rapid uptake into systemic circulation, as well as the potential for controlled drug delivery. Since macromolecules are faced with a number of specific challenges related to permeation through the epithelium, several strategies have been employed historically to improve their buccal absorption and subsequent bioavailability. Several conventional strategies to improve macromolecule penetration include the use of chemical permeation enhancers, enzyme inhibitors and the use of mucoadhesive materials acting as carriers. More recent approach